These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 20571380)

  • 61. Methylphenidate and hypertension.
    Prabhuswamy M; Srinath S; Girimaji S; Seshadri S
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):805-6. PubMed ID: 17201626
    [No Abstract]   [Full Text] [Related]  

  • 62. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl.
    Goetz M; Surman CB; Mlynarova E; Krsek P
    J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167
    [No Abstract]   [Full Text] [Related]  

  • 63. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
    Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389
    [No Abstract]   [Full Text] [Related]  

  • 65. [Risk of psychosis with treatment for ADHD].
    Kooij JJS
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940981
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment.
    Kara T; Akaltun İ
    J Clin Psychopharmacol; 2017 Aug; 37(4):484. PubMed ID: 28492426
    [No Abstract]   [Full Text] [Related]  

  • 67. Priapism associated with methylphenidate: a case report.
    Cakin-Memik N; Yildiz O; Sişmanlar SG; Karakaya I; Ağaoğlu B
    Turk J Pediatr; 2010; 52(4):430-4. PubMed ID: 21043394
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An update on attention deficit disorder.
    Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
    [No Abstract]   [Full Text] [Related]  

  • 69. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 70. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 71. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
    Tan M; Appleton R
    Arch Dis Child; 2005 Jan; 90(1):57-9. PubMed ID: 15613514
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methylphenidate: growth retardation.
    Prescrire Int; 2011 Oct; 20(120):238-9. PubMed ID: 21970086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methylphenidate-induced acute orofacial and extremity dyskinesia.
    Yilmaz AE; Donmez A; Orun E; Tas T; Isik B; Sonmez FM
    J Child Neurol; 2013 Jun; 28(6):781-3. PubMed ID: 22791547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Methylphenidate as a possible cause of thrombocytopenia.
    Kuperman AA; Yaniv I; Stahl B; Tamary H
    Ann Pharmacother; 2003; 37(7-8):1146. PubMed ID: 12841835
    [No Abstract]   [Full Text] [Related]  

  • 76. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder.
    Rizkallah E; Legault L; Pampoulova T; Lévesque S; Bélanger M; Stavro K; Chiasson JP; Potvin S
    Am J Addict; 2011; 20(5):478-9. PubMed ID: 21838849
    [No Abstract]   [Full Text] [Related]  

  • 77. Long-term effects of ADHD medication on adult height: results from the NESARC.
    Peyre H; Hoertel N; Cortese S; Acquaviva E; Limosin F; Delorme R
    J Clin Psychiatry; 2013 Nov; 74(11):1123-4. PubMed ID: 24330902
    [No Abstract]   [Full Text] [Related]  

  • 78. [Methylphenidate misuse].
    Bruggisser M; Bodmer M; Liechti ME
    Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 80. [Antipsychotic agents and stimulants: a judicious combination?].
    de Jong MH; Eussen ML; van Gool AR
    Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.